BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

814 related articles for article (PubMed ID: 26041119)

  • 1. Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study.
    Nonato NL; Nascimento OA; Padilla RP; de Oca MM; Tálamo C; Valdivia G; Lisboa C; López MV; Celli B; Menezes AM; Jardim JR
    Chron Respir Dis; 2015 Aug; 12(3):264-73. PubMed ID: 26041119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population.
    Lopez Varela MV; Montes de Oca M; Wehrmeister FC; Rodriguez C; Ramirez L; Menezes A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1901-1911. PubMed ID: 31692595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between respiratory symptoms and pulmonary function in asbestos-exposed workers.
    Brodkin CA; Barnhart S; Anderson G; Checkoway H; Omenn GS; Rosenstock L
    Am Rev Respir Dis; 1993 Jul; 148(1):32-7. PubMed ID: 8317811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COPD in chronic heart failure: less common than previously thought?
    Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
    Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: the Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) study.
    Montes de Oca M; Tálamo C; Halbert RJ; Perez-Padilla R; Lopez MV; Muiño A; Jardim JRB; Valdivia G; Pertuzé J; Moreno D; Menezes AMB
    Chest; 2009 Jul; 136(1):71-78. PubMed ID: 19349388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies.
    Sansores RH; Ramírez-Venegas A; Hernández-Zenteno R; Mayar-Maya ME; Pérez-Bautista OG; Velázquez Uncal M
    Respir Med; 2013 Apr; 107(4):580-6. PubMed ID: 23313037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
    Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
    BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Restrictive pattern in spirometry: does FEV(1)/FVC need to be increased?].
    Wesołowski S; Boros P
    Pneumonol Alergol Pol; 2011; 79(6):382-7. PubMed ID: 22028116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.
    van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J;
    Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study.
    Miravitlles M; Menezes A; López Varela MV; Casas A; Ugalde L; Ramirez-Venegas A; Mendoza L; López A; Wehrmeister FC; Surmont F; Montes de Oca M
    Respir Med; 2018 Jan; 134():62-69. PubMed ID: 29413510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.
    Weiss G; Steinacher I; Lamprecht B; Kaiser B; Mikes R; Sator L; Hartl S; Wagner H; Studnicka M
    NPJ Prim Care Respir Med; 2017 Jan; 27(1):4. PubMed ID: 28127061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed ratio or lower limit of normal for the FEV
    Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
    Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory symptoms and ventilatory function of the sawmillers in Ibadan, Nigeria.
    Ige OM; Onadeko OB
    Afr J Med Med Sci; 2000 Jun; 29(2):101-4. PubMed ID: 11379437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prevalence of Chronic Obstructive Pulmonary Disease by the Global Lung Initiative Equations in North-Western Russia.
    Andreeva E; Pokhaznikova M; Lebedev A; Moiseeva I; Kutznetsova O; Degryse JM
    Respiration; 2016; 91(1):43-55. PubMed ID: 26727503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study.
    Kubota Y; London SJ; Cushman M; Chamberlain AM; Rosamond WD; Heckbert SR; Zakai N; Folsom AR
    J Thromb Haemost; 2016 Dec; 14(12):2394-2401. PubMed ID: 27696765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal study.
    Perez-Padilla R; Wehrmeister FC; Celli BR; Lopez-Varela MV; Montes de Oca M; Muiño A; Talamo C; Jardim JR; Valdivia G; Lisboa C; Menezes AM;
    PLoS One; 2013; 8(8):e67960. PubMed ID: 23936297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COPD Underdiagnosis and Misdiagnosis in a High-Risk Primary Care Population in Four Latin American Countries. A Key to Enhance Disease Diagnosis: The PUMA Study.
    Casas Herrera A; Montes de Oca M; López Varela MV; Aguirre C; Schiavi E; Jardim JR;
    PLoS One; 2016; 11(4):e0152266. PubMed ID: 27073880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.